Previous studies showed that amylin concentrations in blood and cerebrospinal fluid are higher in AD than in cognitively unaffected persons (12, 13, 38, 39), suggesting a possible relationship between circulating amylin levels and the propensity of amylin to accumulate in the brain. The gene discussed is IAPP; the disease is Alzheimer disease.